Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Novel actions of thiazolidinediones on vascular function and exercise capacity.

Reusch JE, Regensteiner JG, Watson PA.

Am J Med. 2003 Dec 8;115 Suppl 8A:69S-74S. Review.

PMID:
14678869
2.

Vascular reactivity and thiazolidinediones.

Dandona P, Aljada A, Chaudhuri A.

Am J Med. 2003 Dec 8;115 Suppl 8A:81S-86S. Review.

PMID:
14678871
3.

Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.

PMID:
16306801
4.

A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.

Seufert J, Lübben G, Dietrich K, Bates PC.

Clin Ther. 2004 Jun;26(6):805-18. Review.

PMID:
15262452
5.

Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.

Mittermayer F, Schaller G, Pleiner J, Krzyzanowska K, Kapiotis S, Roden M, Wolzt M.

J Clin Endocrinol Metab. 2007 Jul;92(7):2574-80. Epub 2007 May 1.

PMID:
17473072
6.

Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus.

Ríos-Vázquez R, Marzoa-Rivas R, Gil-Ortega I, Kaski JC.

Am J Cardiovasc Drugs. 2006;6(4):231-42. Review.

PMID:
16913824
7.

PPARgamma and atherosclerosis: effects on cell growth and movement.

Hsueh WA, Law RE.

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1891-5. Review.

8.

Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.

Dandona P, Ghanim H, Chaudhuri A, Mohanty P.

J Diabetes Complications. 2008 Jan-Feb;22(1):62-75. doi: 10.1016/j.jdiacomp.2006.10.009. Review.

PMID:
18191079
9.

Thiazolidinediones--tools for the research of metabolic syndrome X.

Komers R, Vrána A.

Physiol Res. 1998;47(4):215-25. Review.

10.

Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.

de Dios ST, Hannan KM, Dilley RJ, Hill MA, Little PJ.

J Diabetes Complications. 2001 May-Jun;15(3):120-7.

PMID:
11358680
11.
12.

Insulin resistance and the effects of thiazolidinediones on cardiac metabolism.

Young LH.

Am J Med. 2003 Dec 8;115 Suppl 8A:75S-80S. Review.

PMID:
14678870
13.

The anti-atherogenic effects of thiazolidinediones.

Stojanovska L, Honisett SY, Komesaroff PA.

Curr Diabetes Rev. 2007 Feb;3(1):67-74. Review.

PMID:
18220657
14.

Vascular function, insulin resistance and fatty acids.

Steinberg HO, Baron AD.

Diabetologia. 2002 May;45(5):623-34. Epub 2002 Apr 4. Review.

PMID:
12107742
15.

Free fatty acids and type 2 diabetes mellitus.

Wyne KL.

Am J Med. 2003 Dec 8;115 Suppl 8A:29S-36S. Review.

PMID:
14678863
16.

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.

Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P.

Diabetes Care. 2004 Feb;27(2):484-90.

PMID:
14747233
17.

Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.

Defronzo RA, Mehta RJ, Schnure JJ.

Hosp Pract (1995). 2013 Apr;41(2):132-47. doi: 10.3810/hp.2013.04.1062.

PMID:
23680744
18.

Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.

Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis BB 3rd, Hawley JA.

Diabetes. 2007 Jul;56(7):1856-64. Epub 2007 Apr 17.

19.

Coronary vasomotor abnormalities in insulin-resistant individuals.

Quiñones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, De La Rosa R, Chon Y, Yang H, Nicholas SB, Modilevsky T, Yu K, Van Herle K, Castellani LW, Elashoff R, Hsueh WA.

Ann Intern Med. 2004 May 4;140(9):700-8.

PMID:
15126253
20.

Supplemental Content

Support Center